JAN

JanOne Inc.

3.48 USD
+0.09 (+2.65%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

JanOne Inc. stock is down -5.95% since 30 days ago. The next earnings date is May 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45.45% of the previous 32 May’s closed higher than April.

About JanOne Inc.

JanOne Inc. focuses on identifying, acquiring, licensing, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease.